People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trident Labs, Inc. | — | Biotechnology | Series A | $14.0M | $506.1M | 2019 |
| Antrum, Inc. | — | Other Technology | Seed | $6.4M | $17.9M | 2022 |
JAMES V. BUZZITTA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JAMES V. BUZZITTA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ADAM T. DONOVAN | 1 | 1 |
| NICHOLAS V. HAVEMAN | 1 | 1 |
| ADAM DONOVAN | 1 | 1 |
| DAN KELSEY | 1 | 1 |
| WOLFGANG V. DAUM | 1 | 1 |
| PAUL V. CONLEY | 1 | 1 |
| LAURENCE V. MARTON | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.